Qiagen NV (Qiagen NV) Inventories, Finished Goods : $212 Mil (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Inventories, Finished Goods?

Qiagen NV's quarterly finished goods increased from Jun. 2023 ($200 Mil) to Sep. 2023 ($211 Mil) and increased from Sep. 2023 ($211 Mil) to Dec. 2023 ($212 Mil).

Qiagen NV's annual finished goods increased from Dec. 2021 ($165 Mil) to Dec. 2022 ($175 Mil) and increased from Dec. 2022 ($175 Mil) to Dec. 2023 ($212 Mil).

Qiagen NV Inventories, Finished Goods Historical Data

The historical data trend for Qiagen NV's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Inventories, Finished Goods Chart

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

98.90

151.33

165.10

174.86

212.45

Qiagen NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Inventories, Finished Goods	Get a 7-Day Free Trial															174.86	189.39	199.71	211.33	212.45

Qiagen NV Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Qiagen NV (Qiagen NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Executives